Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine
AJNR 26:695-701,687, Tardieu,M.,et al, 2005
Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients
Medicine 84:377-385, Melli,G.,et al, 2005
Peripheral Neuropathy in HIV Infected Patients with the Diffuse Infiltrative Lymphocytosis Syndrome
Ann Neurol 41:438-445, Moulignier,A.,et al, 1997
Neurologic Manifestations of HIV Infection
Ann Int Med 121:769-785, Simpson,D.M.&Tagliati,M., 1994
Acute Diffuse Leukoencephalitis HIV-1 Infection
JNNP 57:105-107, Luer,W.,et al, 1994
High-dose Zidovudine Induction in HTLV-I-Associated Myelopathy:Safety and Possible Efficacy
Neurol 43:2125-2129, Sheremata,W.A.,et al, 1993
Therapy for Human Immunodeficiency Virus Infection
NEJM 328:1686-1695, Hirsch,M.S.&D'Aquila,R., 1993
Ziduvudine Treatment of the AIDS Dementia Complex:Results of a Placebo-Controlled Trial
Ann Neurol 33:343-349, Sidtis,J.J.,et al, 1993
Human Immunodeficiency Virus Type 1 Infection and Myopathy:Clinical Relevance of Zidovudine Therapy
Ann Neurol 34:206-211, Grau,J.M.,et al, 1993
Myopathies Assoc with HIV and Zidovudine:Can Their Effects be Distinguished?
Neurol 43:971-976, Simpson,D.M.,et al, 1993
Improvement of Motor Performance of HIV-Positive Patients Under AZT Therapy
Neurol 42:891-896, Arendt,G.,et al, 1992
Depletion of Muscle Mitochondrial DNA in AIDS Patients with Zidovudine-Induced Myopathy
Lancet 337:508-510, Arnaudo,E.,et al, 1991
Acquired Immunodeficiency Syndrome, CSF Before & During Long-Term Oral Zidovudine Therapy
Arch Neurol 48:695-699, Tartaglione,T.A.,et al, 1991
Prognosis in AZT Myopathy
Neurol 41:1181-1184, Chalmers,A.C.,et al, 1991
Myopathy in Human Immunodeficiency Virus-Infected Children Receiving Long-Term Zidovudine Therapy
J Pediatr 119:152-155, Walter,E.B.,et al, 1991
Zidovudine Myopathy:A Distinctive Disorder Associated with Mitochondrial Dysfunction
Ann Neurol 29:606-614, Mhiri,C.,et al, 1991
Fatigue and Myalgia in AIDS Patients
Neurol 41:1603-1607, Miller,R.G.,et al, 1991
Myopathy with Human Immunodeficiency Virus Type I (HIV-1) Infection:HIV-1 or Zidovudine?
Ann Int Med 113:492-493, Till,M.&MacDonell,K., 1990
Mitochondrial Myopathy Caused by Long-Term Ziduvudine Therapy
NEJM 322:1098-1105, Dalakas,M.C.,et al, 1990
AIDS and the Nervous System
JAMA 261:2396-2399, Dalakas,M.,et al, 1989
The Acquired Immunodeficiency Syndrome (AIDS) Dementia Complex
Ann Int Med 111:400-410, Ho,D.D.,et al, 1989
Zidovudine-Associated Myopathy
Am J Med 86:814-818, Gertner,E.,et al, 1989
Declining Incidence of AIDS Dementia Complex after Introduction of Zidovudine Treatment
BMJ 299:819-821, Portegies,P.,et al, 1989
Retroviruses in the Nervous System:Neurological Involv in AIDS
Neurological Disorders Assoc with HTLV-I, NIH Symposium (Suppl) , Ann Neurol 23:S1-S2178., , 1988
Severe Polymyositis-Like Syndrome Associated with Zidovudine Therapy of AIDS & ARC
NEJM 318:708, Bessen,L.J.,et al, 1988
Acute Meningo-Encephalitis on Dose Reduction of Zidovudine
Lancet 1:1249-1252, Helbert,M.,et al, 1988
Treatment of Infections Associated with Human Immunodeficiency Virus
NEJM 318:1439-1448, Glatt,A.E.,et al, 1988
Response of Human-Immunodeficiency-Virus-Associated Neurological Disease to 3'-Azido-3'-Deoxythymidine
Lancet 1:132-135, Yarchoan,R.,et al, 1987
Possible Drug Interaction During Therapy with Azidothymidine & Acyclovir for AIDS
NEJM 316:547, Bach,M.C., 1987
Zidovudine (AZT)
Editorial, Lancet 1:957-9581987., , 1987